This blog is based on the chapter: Saatchi, A. G. (2026). The Role of Technology in Tackling Global Health Challenges. In Addressing Global Health Challenges Through Financial Innovation and Health Technologies. IGI Global Scientific Publishing. Full chapter available here: Read the full chapter. Technology is often presented as one of the most powerful forces to shape the future of global health. It can support earlier diagnosis, improve disease surveillance, expand remote c

This blog is based on the chapter: Saatchi, A. G. (2026). The Role of Technology in Tackling Global Health Challenges. In Addressing Global Health Challenges Through Financial Innovation and Health Technologies. IGI Global Scientific Publishing. Full chapter available here: Read the full chapter. Global health is often discussed through the language of hospitals, doctors, medicines, and treatments. But the true scope of global health is much wider. It is shaped not only by c

In November 2025, the Global Policy Network brought together healthcare leaders from pharmacy, primary care, policy, and digital health to ask a timely question: could neighbourhood care models be the key to stronger primary care and better population health outcomes? The discussion explored key challenges, including fragmented patient records, workforce pressures, and the practical realities of implementing integrated care. In the UK, cardiovascular disease, kidney disease

Nigeria’s pharmaceutical system is entering a defining moment. For decades, it has operated with fragmented coordination, limited manufacturing capacity, and heavy dependence on donor-driven delivery models. Today, these long-standing pressures have reached a critical point. The departure of global pharmaceutical companies, rising medicine prices and the approaching 2028 transition away from vaccine funding have created an environment where the system to confront realities ca

Medicines sit at the centre of almost every patient interaction across the NHS. Yet the systems designed to support their safe and effective use remain fragmented, unevenly digitised, and often disconnected from the realities of frontline care. While policy ambition around digital transformation has accelerated, the practical conditions needed to translate data into better medicines use have not always kept pace. These themes shaped the fifth roundtable in the UK Medicines Po

As the NHS undergoes profound technological, educational and workforce shifts, pharmacy must evolve alongside it. The fourth roundtable of the UK Medicines Policy Series, hosted by the Global Policy Network (GPN), examined this moment of transition through a unifying lens: innovation. Chair Reena Patel captured the purpose of the session clearly: “We will explore the future of the profession through that lens of innovation and explore how pharmacy can drive better outcomes th

The NHS is asking more of pharmacists than ever before, yet the systems designed to support them have not kept pace. As workforce pressures intensify across the health service, pharmacy at a critical juncture: highly trained, widely accessible, and increasingly essential, but still constrained by structural barriers. Today, that is evolving into a new strategic frontier, one that asks; " How do we develop and utilise the pharmacy workforce to meet growing system needs?". Thi

In Britain’s crowded primary care landscape, pharmacists occupy a quiet corner. Pressure across healthcare systems in the United Kingdom (UK) has increased in recent years, while community pharmacy has remained limited in authority. Today, this silent resilience is on the verge of a discreet yet significant transformation: from clinical urgency to strategic transitions. By embedding Independent Prescribing (IP) as a lever for the future of primary care, we aim to translate pa

Nigeria’s Joint Annual Review (JAR) 2025 offers one of the clearest signals yet that the country’s health sector is not just reforming it is transforming. Twenty-three months into the Health Sector Renewal Investment Initiative (NHSRII), the results are becoming visible, measurable, and scalable. This year’s review brought together leaders from Federal, State, and Local Governments, the private sector, civil society, and development partners under the theme: All Hands, One M

It's time to stop viewing pharmacy as a simple transaction and start recognising it as afoundational pillar of modern healthcare. This was one of the central messages of the first roundtable of the UK Medicine Policy series hosted by the Global Policy Network (GPN) on June 25, 2025. The roundtable brought together colleagues from the NHS, industry, the Commonwealth, and international health systems, fostering the cross-sector dialogue essential for transformative change. It w